Quick Takeaways
- Sio Capital Management, LLC filed SCHEDULE 13G for Bright Minds Biosciences Inc. Common Shares (DRUG).
- Disclosed ownership: 6.5%.
- Date of event: 31 Dec 2024.
Sio Capital Management, LLC - 31 Dec 2024 SCHEDULE 13G Report for Bright Minds Biosciences Inc. Common Shares (DRUG)
- Filing Manager
- Sio Capital Management, LLC
- Reporting Manager
- Sio Capital Management, LLC
- Symbol
- DRUG
- Shares outstanding
- 6,950,662 shares
- Disclosed Ownership
- 451,793 shares
- Ownership
- 6.5%
- Form type
- SCHEDULE 13G
- Filing time
- 10 Feb 2025, 12:56:05 UTC
- Date of event
- 31 Dec 2024
- Next filing
- 08 Apr 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"Sio Capital Management, LLC disclosed 6.5% ownership in Bright Minds Biosciences Inc. Common Shares (DRUG) on 31 Dec 2024."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 10 Feb 2025, 12:56.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (1)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Sio Capital Management, LLC | 6.5% | 451,793 | 0 | 451,793 | /s/ Jin W. Lee | Chief Compliance Officer |